One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...

Scientists from Rutgers University and Brookhaven National Laboratory collaborated on this ongoing research and published a ...

ProtGPS predicts protein localization, offering insights into function and disease. The AI model identifies mutations that alter localization, revealing potential disease mechanisms. Researchers ...

Jacob Halaska, ©Index Stock Imagery Researchers like mice. US government statistics reveal that the whiskered ones show up in 90% of all experiments. Mice come cheap, procreate often, and die fairly ...

The pivotal trial for Neurogene's Rett syndrome gene therapy makes use of baseline controls and a rigorous endpoint that ...

CARLSBAD, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases ...

A recent study confirms that people with Parkinson's disease have different gut microbiota compared with healthy individuals, suggesting that bacterial imbalance may play a role in this condition.

Shares of Design Therapeutics Inc. DSGN dropped 45% in premarket trading Tuesday after the biopharma company reported mixed results from an early-stage trial of a treatment for Friedreich ataxia ...

The research paper, “APOLLOE4 Phase 3 Study of Oral ALZ-801/Valiltramiprosate in APOE ε4/ε4 Homozygotes with Early Alzheimer’s Disease: Trial Design & Baseline Characteristics,” was ...

BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025) ...

A report on the researchers' proof-of-concept work on laboratory-cultured cells and mice appears in the March 11 issue of Molecular Therapy—Nucleic Acids and could pave the way for therapies for ...

A new startup founded by a former Google DeepMind scientist is exiting stealth with $50 million in funding.. Latent Labs is building AI foundation models to “make biology programmable,” and it ...